Cargando…

Report of chronic myeloid leukemia in chronic phase from Cancer Institute (Women India Association), Chennai, 2002-2009

Cancer Institute Chennai is the first Institute of Oncological sciences to be established in the country. In ICON meeting, they presented the data of 516 patients, of which 91% patients achieved complete hematological response. The overall survival was 88% and event free survival was 65% at 5 years.

Detalles Bibliográficos
Autores principales: Ganesan, Prasanth, Rejiv, R., Manjunath, N., Sanju, C., Sagar, T. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902627/
https://www.ncbi.nlm.nih.gov/pubmed/24516312
http://dx.doi.org/10.4103/0971-5851.123744
_version_ 1782301017042321408
author Ganesan, Prasanth
Rejiv, R.
Manjunath, N.
Sanju, C.
Sagar, T. G.
author_facet Ganesan, Prasanth
Rejiv, R.
Manjunath, N.
Sanju, C.
Sagar, T. G.
author_sort Ganesan, Prasanth
collection PubMed
description Cancer Institute Chennai is the first Institute of Oncological sciences to be established in the country. In ICON meeting, they presented the data of 516 patients, of which 91% patients achieved complete hematological response. The overall survival was 88% and event free survival was 65% at 5 years.
format Online
Article
Text
id pubmed-3902627
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-39026272014-02-10 Report of chronic myeloid leukemia in chronic phase from Cancer Institute (Women India Association), Chennai, 2002-2009 Ganesan, Prasanth Rejiv, R. Manjunath, N. Sanju, C. Sagar, T. G. Indian J Med Paediatr Oncol Original Article Cancer Institute Chennai is the first Institute of Oncological sciences to be established in the country. In ICON meeting, they presented the data of 516 patients, of which 91% patients achieved complete hematological response. The overall survival was 88% and event free survival was 65% at 5 years. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3902627/ /pubmed/24516312 http://dx.doi.org/10.4103/0971-5851.123744 Text en Copyright: © Indian Journal of Medical and Paediatric Oncology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Ganesan, Prasanth
Rejiv, R.
Manjunath, N.
Sanju, C.
Sagar, T. G.
Report of chronic myeloid leukemia in chronic phase from Cancer Institute (Women India Association), Chennai, 2002-2009
title Report of chronic myeloid leukemia in chronic phase from Cancer Institute (Women India Association), Chennai, 2002-2009
title_full Report of chronic myeloid leukemia in chronic phase from Cancer Institute (Women India Association), Chennai, 2002-2009
title_fullStr Report of chronic myeloid leukemia in chronic phase from Cancer Institute (Women India Association), Chennai, 2002-2009
title_full_unstemmed Report of chronic myeloid leukemia in chronic phase from Cancer Institute (Women India Association), Chennai, 2002-2009
title_short Report of chronic myeloid leukemia in chronic phase from Cancer Institute (Women India Association), Chennai, 2002-2009
title_sort report of chronic myeloid leukemia in chronic phase from cancer institute (women india association), chennai, 2002-2009
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902627/
https://www.ncbi.nlm.nih.gov/pubmed/24516312
http://dx.doi.org/10.4103/0971-5851.123744
work_keys_str_mv AT ganesanprasanth reportofchronicmyeloidleukemiainchronicphasefromcancerinstitutewomenindiaassociationchennai20022009
AT rejivr reportofchronicmyeloidleukemiainchronicphasefromcancerinstitutewomenindiaassociationchennai20022009
AT manjunathn reportofchronicmyeloidleukemiainchronicphasefromcancerinstitutewomenindiaassociationchennai20022009
AT sanjuc reportofchronicmyeloidleukemiainchronicphasefromcancerinstitutewomenindiaassociationchennai20022009
AT sagartg reportofchronicmyeloidleukemiainchronicphasefromcancerinstitutewomenindiaassociationchennai20022009